AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
an hour ago

Seabees Modernize Airfield Repair on Historical Iceland Footprint

DVIDS - Georgia

fallback image
Aug. 28, 2026

Defending the “High North”, Exercise Northern Viking 2026 kicks off in Iceland

DVIDS - Georgia

fallback image
Aug. 21, 2026

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

GlobeNewswire, Inc.

fallback image
Aug. 31, 2026

Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations

GlobeNewswire, Inc.

fallback image
Aug. 19, 2026

North America’s Authentic Icelandic Skyr Celebrates Autumn: Icelandic Provisions Launches Pumpkin Spice

EIN Presswire

fallback image
Aug. 18, 2026

Exercise Northern Viking 2026 Marks 75 Years Of U.S.-Iceland Defense Cooperation

DVIDS - Georgia

fallback image
Jul. 9, 2026

Icelandirect Earns SSCI Certification, Strengthening Its Ability to Serve Brands Selling Across Major Retail Channels

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

fallback image
Aug. 30, 2026

86th MDG stretches aeromedical evacuation capabilities in the High North during Northern Viking 26

DVIDS - Georgia

fallback image
Aug. 27, 2026

Alvotech to present at upcoming investor conferences in September

GlobeNewswire, Inc.

fallback image
Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

GlobeNewswire, Inc.

fallback image
May 27, 2026

Icelandirect Achieves FSSC 22000 Certification, Reinforcing Its Commitment to the Highest Standards in Supplement Manufacturing

GlobeNewswire, Inc.

fallback image
Jun. 11, 2026

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

GlobeNewswire, Inc.

fallback image
Jun. 9, 2026

Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease

GlobeNewswire, Inc.

fallback image
Jun. 8, 2026

Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference

GlobeNewswire, Inc.

fallback image
Aug. 24, 2026

First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis

GlobeNewswire, Inc.

fallback image
May 29, 2026

Naval Medical Forces Atlantic Honors Capt. Chad McKenzie Upon Retirement After 30 Years of Distinguished Naval Service

DVIDS - Georgia

fallback image
Apr. 6, 2026

Icelandic firm sets up ‘tapering clinic’ in Maine

Maine International Trade Center

fallback image
May 19, 2026

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

GlobeNewswire, Inc.

fallback image
May 18, 2026

New Memoranda pave the way for €50 million in investments in local development and public health

Government of Slovenia

Sign up for:

Iceland Health Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: